 WATERTOWN, Mass., Dec. 08, 2020 GLOBE NEWSWIRE -- EyePoint Pharmaceuticals, Inc. NASDAQ: EYPT, a pharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced that it will effect a 1-for-10 reverse stock split at 5:00 p.m. Eastern Time today. Beginning with the opening of trading on December 9, 2020, EyePoints common stock will trade on the Nasdaq Global Market on a split-adjusted basis under a new CUSIP number 30233G209. 